News und Analysen
![EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
![Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
![Unaudited NAV for November 2022](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Unaudited NAV for November 2022
Unaudited NAV for November 2022
![Arix to Present at Mello Investment Trusts & Funds](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Arix to Present at Mello Investment Trusts & Funds
Arix to Present at Mello Investment Trusts & Funds
![Unaudited NAV for October 2022](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Unaudited NAV for October 2022
Unaudited NAV for October 2022
![Holding(s) in Company](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Holding(s) in Company
Holding(s) in Company
![Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
![Unaudited NAV for September 2022](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Unaudited NAV for September 2022
Unaudited NAV for September 2022
![Director/PDMR Shareholding](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Director/PDMR Shareholding
Director/PDMR Shareholding
![Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022
Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022
![Unaudited NAV for August 2022](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Unaudited NAV for August 2022
Unaudited NAV for August 2022
![DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
![Unaudited NAV for July 2022](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Unaudited NAV for July 2022
Unaudited NAV for July 2022
![Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
![Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
![Arix Bioscience plc Announces Changes to Board of Directors](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Arix Bioscience plc Announces Changes to Board of Directors
Arix Bioscience plc Announces Changes to Board of Directors
![Interim Results for the Six Months Ended 30 June 2022](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Interim Results for the Six Months Ended 30 June 2022
Interim Results for the Six Months Ended 30 June 2022
![Notice of Results & Investor Presentation](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Notice of Results & Investor Presentation
Notice of Results & Investor Presentation
![Unaudited NAV for June 2022](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Unaudited NAV for June 2022
Unaudited NAV for June 2022
![Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany
Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany
![Tetragon Financial Group (TFG): Offering a diverse exposure to alternative assets](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Tetragon Financial Group (TFG): Offering a diverse exposure to alternative assets
Tetragon Financial Group (TFG): Offering a diverse exposure to alternative assets
![DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B funding of HR-Tech company WorkMotion](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B funding of HR-Tech company WorkMotion
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B funding of HR-Tech company WorkMotion
![Notice of Investor Presentation](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Notice of Investor Presentation
Notice of Investor Presentation
![Unaudited NAV for May 2022](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Unaudited NAV for May 2022
Unaudited NAV for May 2022
![Result of Annual General Meeting 2022](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Result of Annual General Meeting 2022
Result of Annual General Meeting 2022